Both the use of next-generation sequencing (NGS) testing for cancer and the rate of claim denials for such testing increased between 2016 and 2021, despite implementation of a recent Medicare national ...
Genetic tests make up a growing share of total spending on laboratory tests under Medicare Part B, according to a report posted last week by the HHS’ Office of Inspector General. They comprised 43% of ...
A Jan. 28 report on Medicare spending on lab tests indicated that spending on many types of tests flattened between 2022 and 2024, but spending on genetic tests rose 20% between 2023 and 2024 to $3.6 ...
Myriad Genetics, Inc., a leader in molecular diagnostics and personalized medicine, today announced that Palmetto GBA, a Medicare Administrative Contractor (MAC) that assesses molecular diagnostic ...
Dana-Farber’s Katherine Janeway, M.D., discusses how reimbursement policies for molecular diagnostics have failed to keep pace with scientific evidence, leaving gaps in the care for pediatric bone ...
When you have a rare disease, managing doctor’s appointments, prescriptions and care plans is difficult enough — figuring out what Medicare will (and won’t) cover often adds another layer of stress.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results